Indian Pharmaceutical Market reports slower growth in October
Contribution from the top five therapies stood at 58% of IPM in October 2021. These therapies are cardiac, anti-infectives, gastro-intestinal, anti-diabetic and vitamins
Contribution from the top five therapies stood at 58% of IPM in October 2021. These therapies are cardiac, anti-infectives, gastro-intestinal, anti-diabetic and vitamins
India registers 18% of deaths annually due to air pollution while seven million die annually across the world due to air pollution
The industry is at an inflection point and it awaits mega investments, the right government policies, and the creation of a strong ecosystem to propel innovation
Branded and unbranded versions of the first-ever interchangeable biosimilar in the U.S. provide more affordable options for the millions of Americans living with diabetes
If approved or authorized, Paxlovid would be the first oral antiviral of its kind, to combat SARS-CoV-2
Covaxin is the only Covid-19 vaccine to have demonstrated efficacy data from phase III clinical trials against the Delta variant at 65.2%
Bioanalytical approach to accelerate development efforts in the identification of compounds that can treat chlorine or sulfur mustard injuries
Biocon Biologics and Viatris co-developed the products
It is the first U.S. FDA approved novel topical mechanism for acne in nearly 40 years
The Phase 3 study is designed to bridge data collected from the vaccine efficacy trial conducted in India to the U.S. population
Subscribe To Our Newsletter & Stay Updated